Clinical trial
Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
NCT00004008 · University of Glasgow, Other · Completed
Key facts
| NCT number | NCT00004008 |
|---|---|
| Title | Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer |
| Official title | A Phase II Trial of Bryostatin 1 in Ovarian Cancer Administered by Weekly 24 Hour Intravenous Infusion |
| Lead sponsor | University of Glasgow, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | bryostatin 1 |
| Start date | Jul 1, 1999 |
| Completion | May 1, 2003 |
| First posted | May 8, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: